Boca Raton, FL -- (SBWIRE) -- 09/27/2013 -- StockFreak scours the market on a daily basis looking for the hottest penny stocks that may be the next big runners. StockFreak focuses on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks – Transcept Pharmaceuticals Inc(NASDAQ:TSPT), Corporate Resource Services Inc(NASDAQ:CRRS), Aratana Therapeutics Inc(NASDAQ:PETX), Vista Gold Corp.(NYSEMKT:VGZ)
Transcept Pharmaceuticals Inc(NASDAQ:TSPT) traded with sharp volume of 318,083.00 shares while the average trading volume remained 219,350.00 shares. The stock showed a downward trend in prior session and plunged -9.76% and finally closed the trading session at price $3.33. Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of proprietary products that address therapeutic needs in the field of neuroscience. Transcept Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Point Richmond, California.
Is TSPT a Solid Investment at These Levels? Read This Report For Details
Corporate Resource Services Inc(NASDAQ:CRRS) stayed at -20.40% to closed at $2.38.The stock, remained with heavy volume of 1.02 million shares and its average volume remained 105,874.00 shares. The day range of the stock was amid $2.09 - $3.01, while the 52 week remained $0.35 - $5.62. Corporate Resource Services, Inc. provides diversified staffing, recruiting, and consulting services in the United States. It offers trained employees in the areas of insurance, information technology, accounting, legal, engineering, science, healthcare, life sciences, creative services, hospitality, retail, general business, and light industrial work.
How Should Investors Trade CRRS Now? Don’t Miss out a Special Trend Analysis
Aratana Therapeutics Inc(NASDAQ:PETX) in prior session, moved down -17.67% and, at the end of the day, closed the session at $15.33.
The stock traded with volume of 120,128.00 shares in the last session, as compared to average volume of 60,466.00 shares. The market capitalization of the company was of 488.95 million. Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of prescription medicines for pets in the United States and Europe. The company was founded in 2010 and is headquartered in Kansas City, Kansas.
Can PETX Show a Strong Recovery? Find out in This Research Report
Vista Gold Corp.(NYSEMKT:VGZ), in preceding trading session, showed a bearish movement of -16.95% and remained with market capitalization of 40.08 million. The stock gained volume of 4.02 million shares in prior session, while the average volume was 1.25 million shares. The YTD trend of the stock remained negative -81.01%. Vista Gold Corp. focuses on the evaluation, acquisition, exploration, and advancement of gold exploration and potential development projects primarily in Australia, North America, and Indonesia. Vista Gold Corp. was founded in 1983 and is based in Littleton, Colorado.
Where VGZ is Headed Exactly? Find out in This Trend Analysis Reports
StockFreak scours the market on a daily basis looking for the hottest penny stocks that may be the next big runners. We strive to provide you with only the most opportunistic picks by pouring over mountains of data and charts. How often we send out our alerts is dependent on how often we find something worthwhile.
GENERAL NOTICE AND DISCLAIMER - PLEASE READ CAREFULLY THE FOLLOWING NOTICE AND DISCLAIMER MUST BE READ AND UNDERSTOOD AND YOU MUST AGREE TO THE TERMS CONTAINED THEREIN BEFORE USING THIS WEBSITE OR SUBSCRIBING TO OUR NEWSLETTER.
We are engaged in the business of advertising and promoting companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. Neither the owner of StockFreak.com nor any of its members, officers, directors, contractors or employees are licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed on StockFreak.com. It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. StockFreak.com makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website.
StockFreak.com has been retained by an unrelated third party to perform promotional and advertising services for a limited time with respect to the company we are profiling or discussing on this website and in exchange for such services has received cash compensation from such third party. Questions regarding this website may be sent to info@StockFreak.com.
Read Our Disclaimer at: http://www.stockfreak.com/disclaimer.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)